Bioera S.p.A. (BIE.MI)

EUR 0.04

(0.0%)

EBITDA Summary of Bioera S.p.A.

Bioera S.p.A.'s latest annual EBITDA in 2023 was -3.19 Million EUR , up 41.27% from previous year.
Bioera S.p.A.'s latest quarterly EBITDA in 2024 Q2 was 15 Million EUR , up 1118.25% from previous quarter.
Bioera S.p.A. reported an annual EBITDA of -4.59 Million EUR in 2022, down -28.95% from previous year.
Bioera S.p.A. reported an annual EBITDA of 16.09 Million EUR in 2021, up 50.47% from previous year.
Bioera S.p.A. reported a quarterly EBITDA of -1.47 Million EUR for 2023 Q4, down -116.45% from previous quarter.
Bioera S.p.A. reported a quarterly EBITDA of -681 Thousand EUR for 2023 Q2, up 75.06% from previous quarter.

Annual EBITDA Chart of Bioera S.p.A. (2023 - 2005)

Historical Annual EBITDA of Bioera S.p.A. (2023 - 2005)

Year	EBITDA	EBITDA Growth
2023	-3.19 Million EUR	41.27%
2022	-4.59 Million EUR	-28.95%
2021	16.09 Million EUR	50.47%
2020	-4.72 Million EUR	-4.72%
2019	-4.1 Million EUR	-279.77%
2018	-2.3 Million EUR	65.26%
2017	-4.07 Million EUR	-322.18%
2016	-942 Thousand EUR	-14.65%
2015	-1.22 Million EUR	-38.13%
2014	-2.42 Million EUR	-206.6%
2013	1.16 Million EUR	-85.31%
2012	4.16 Million EUR	-57.97%
2011	9.37 Million EUR	678.66%
2010	1.16 Million EUR	-19.13%
2009	-8.16 Million EUR	-73.91%
2008	5.53 Million EUR	-15.63%
2007	6.55 Million EUR	-8.53%
2006	7.16 Million EUR	0.76%
2005	7.11 Million EUR	0.0%

Year	EBITDA	EBITDA Growth
2024 Q2	15 Million EUR	1118.25%
2023 Q4	-1.47 Million EUR	-116.45%
2023 Q2	-681 Thousand EUR	75.06%
2023 FY	- EUR	41.27%
2022 Q4	-2.73 Million EUR	-203.44%
2022 FY	- EUR	-28.95%
2022 Q2	-900 Thousand EUR	40.75%
2021 Q2	-1.24 Million EUR	71.56%
2021 FY	- EUR	50.47%
2021 Q4	-1.51 Million EUR	-22.3%
2020 Q2	-2.27 Million EUR	43.44%
2020 FY	- EUR	-4.72%
2020 Q4	-4.36 Million EUR	-91.79%
2019 FY	- EUR	-279.77%
2019 Q4	-4.02 Million EUR	-132.85%
2019 Q2	-1.72 Million EUR	-210.97%
2018 Q4	-556 Thousand EUR	39.17%
2018 Q2	-914 Thousand EUR	41.63%
2018 FY	- EUR	65.26%
2017 Q4	-1.56 Million EUR	-32.38%
2017 FY	- EUR	-322.18%
2017 Q2	-1.18 Million EUR	-14.08%
2016 Q4	-1.03 Million EUR	-453.92%
2016 FY	- EUR	-14.65%
2016 Q2	293 Thousand EUR	206.55%
2015 Q2	-397 Thousand EUR	57.36%
2015 Q4	-275 Thousand EUR	30.73%
2015 FY	- EUR	-38.13%
2014 Q4	-931 Thousand EUR	-616.15%
2014 Q2	-130 Thousand EUR	77.03%
2014 FY	- EUR	-206.6%
2013 Q2	236 Thousand EUR	0.0%
2013 FY	- EUR	-85.31%
2013 Q4	-566 Thousand EUR	-339.83%
2012 FY	- EUR	-57.97%
2011 FY	- EUR	678.66%
2011 Q2	- EUR	0.0%
2010 Q2	- EUR	0.0%
2010 FY	- EUR	-19.13%
2009 Q2	- EUR	0.0%
2009 FY	- EUR	-73.91%
2008 FY	- EUR	-15.63%
2007 FY	- EUR	-8.53%
2006 FY	- EUR	0.76%
2005 FY	- EUR	0.0%

Peer EBITDA Comparison of Bioera S.p.A.

Name	EBITDA	EBITDA Difference
GPI S.p.A.	67.95 Million EUR	104.7%
Poste Italiane S.p.A.	3.97 Billion EUR	100.08%